Chilkoti Group

The Chilkoti group carries out research in two areas: (1) Biomolecular Materials, with a focus on genetically encoded stimulus responsive peptide polymers and fusion proteins for application in protein purification and drug delivery; and (2) Biointerface Science, with a focus on protein-polymer conjugates, the development of low-cost, point-of-care clinical diagnostics, and plasmonic biosensors.

Recent Publications

S. A. Costa, Mozhdehi, D. , Dzuricky, M. J. , Isaacs, F. J. , Brustad, E. M. , and Chilkoti, A. , Active Targeting of Cancer Cells by Nanobody Decorated Polypeptide Micelle with Bio-orthogonally Conjugated Drug, Nano Letters, 2018.
S. Banskota, Yousefpour, P. , Kirmani, N. , Li, X. , and Chilkoti, A. , Long circulating genetically encoded intrinsically disordered zwitterionic polypeptides for drug delivery, Biomaterials, vol. 192, pp. 475-485, 2019.
E. M. Mastria, Cai, L. Y. , Li, X. , Schaal, J. L. , and Chilkoti, A. , Nanoparticle formulation improves doxorubicin efficacy by enhancing host antitumor immunity, Journal of Controlled Release, vol. 269, pp. 364-373, 2018.

We are a Duke Green Lab